News and Events – COD Research

WDSC-Web-Upcoming

11 months ago

WDSC upcoming

Posted by cppl_codresearch_2022

Bio-2024-Attendee-Web-01_ Upcoming

Bio 2024 upcoming

World Drug safety Congress Europe 2023 in Amsterdam, Netherlands

DIA 2023 in Boston, Massachusetts

CODE Exhibiting at BIO 2024

DCAT 2023 in New York City

Scope 2023 in Orlando, Florida

Events

3 years ago

Pharmacovigilance System guideline of South Africa – A high level glance

Events

2 years ago

COD research is delighted to present on “Career Opportunities in Pharmacovigilance”

Events

2 years ago

An insightful session on “ISO: 14155- Introduction to Clinical Investigation for Medical Devices” by Dr. Ashok Thakkar

Events

2 years ago

38th International Society for Pharmacoepidemiology (ICPE)

Events

2 years ago

We are delighted to welcome Mohit Kapoor as Director – Project Management and Operations Strategy

Events

2 years ago

We are the silver sponsor at WDSC-2022

Events

2 years ago

Dr Jay Dave is among the selected speakers to give a presentation during the event.

Events

2 years ago

Experts at our Booth # 42 are awaiting your presence to unlock your Drug Safety Challenges and enhance compliance.

Events

2 years ago

CPhI Frankfurt is calling!

Events

2 years ago

COD Research USA INC is attending World Drug Safety Congress – 2022, Boston.

Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn
Source: EMA Published on 2025-03-21
Release notes - production release version 1.7.2514-3 - 21 March 2025 - Veterinary Medical Products Regulation: Union Product Database
Source: EMA Published on 2025-03-21
Mandate, objectives and rules of procedure for the CVMP Pharmacovigilance Working Party (PhVWP-V)
Source: EMA Published on 2025-03-21
2024 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
Source: EMA Published on 2025-03-20
PSUSA/00000329/202407
Source: EMA Published on 2025-03-20
Minutes of the HMPC meeting 20-22 January 2025
Source: EMA Published on 2025-03-20
EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples
Source: EMA Published on 2025-03-20
Emblaveo
Source: EMA Published on 2025-03-20
PSUSA/00010511/202407
Source: EMA Published on 2025-03-19
Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Revision: 11, Status: Authorised
Source: EMA Published on 2025-03-19
Human medicines European public assessment report (EPAR): Rasagiline ratiopharm, rasagiline, Date of authorisation: 12/01/2015, Revision: 9, Status: Authorised
Source: EMA Published on 2025-03-19
PSUSA/00002944/202407
Source: EMA Published on 2025-03-19
PSUSA/00002087/202407
Source: EMA Published on 2025-03-19
PSUSA/00000081/202408
Source: EMA Published on 2025-03-19
EMEA-003149-PIP01-21-M02
Source: EMA Published on 2025-03-19

Know Which Medication Is Right for Your Seasonal Allergies
Source: FDA Published on 2024-06-25
Sani-Care Salon Products, Inc. - 673747 - 04/24/2024
Source: FDA Published on 2024-06-25
Glenmark Pharmaceuticals Inc., USA Issues Voluntary Nationwide Recall for Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due to Failed Dissolution
Source: FDA Published on 2024-06-25
Report | Drug Shortages: Root Causes and Potential Solutions
Source: FDA Published on 2024-06-24
FDA approves treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults
Source: FDA Published on 2024-06-24
Facilitating Generic Drug Product Development through Product-Specific Guidances - 04/25/2024
Source: FDA Published on 2024-06-24
Modernizing the New Drugs Regulatory Program
Source: FDA Published on 2024-06-24
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Source: FDA Published on 2024-06-21
Public Workshop: Best Practices for Meeting Management Under PDUFA VII - 07/22/2024
Source: FDA Published on 2024-06-21
Center for Drug Evaluation and Research National Survey on Numerical Claims in Prescription Drug Advertising
Source: FDA Published on 2024-06-20
Infla-650 contains hidden drug ingredients
Source: FDA Published on 2024-06-20
Cefdinir - Oral products
Source: FDA Published on 2024-06-20
Considerations in Demonstrating Interchangeability With a Reference Product: Update
Source: FDA Published on 2024-06-20
Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection
Source: FDA Published on 2024-06-20
FDA updates guidance on interchangeability
Source: FDA Published on 2024-06-20

Suzhou Surgicare disposable Hysteroscopy Sheath– Recall due to withdrawn CE certificate, (DSI/2025/001)
Source: MHRA Published on 2025-03-19
Field Safety Notices: 10 to 14 March 2025
Source: MHRA Published on 2025-03-19
Class 4 Medicines Defect Notification: Azithromycin 250 mg Capsules, EL(25)A/11
Source: MHRA Published on 2025-03-11
Field Safety Notices: 3 to 7 March 2025
Source: MHRA Published on 2025-03-11
Class 2 Medicines Recall: Boots Paracetamol 500 mg tablets (16s), EL(25)A/10
Source: MHRA Published on 2025-03-04
Class 2 Medicines Recall: Sun Pharmaceutical Industries Europe B.V., Pemetrexed 1000MG/100ML (10mg/ml) & 800MG/ML (8mg/ml) Infusion bag, EL(25)A/09
Source: MHRA Published on 2025-03-04
Field Safety Notices: 24 to 28 February 2025
Source: MHRA Published on 2025-03-04
Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection, EL(25)A/08
Source: MHRA Published on 2025-03-03
Field Safety Notices: 17 to 21 February 2025
Source: MHRA Published on 2025-02-25
Class 3 Medicines Recall: Glucophage SR 500 mg, 750mg and 1000mg Prolonged-release Tablets, EL(25)A/07
Source: MHRA Published on 2025-02-20
Field Safety Notices: 10th - 14th February 2025
Source: MHRA Published on 2025-02-14
Field Safety Notices: 3 to 7 February 2025
Source: MHRA Published on 2025-02-12
Class 4 Medicines Notification: Lansoprazole Gastro-resistant Hard Capsules 15mg, EL(25)A/06
Source: MHRA Published on 2025-02-11
Class 2 Medicines Recall: Nitrofurantoin CNX Therapeutics 100 mg Prolonged-Release capsules, EL(25)A/05
Source: MHRA Published on 2025-02-05
Field Safety Notices: 27 to 31 January 2025
Source: MHRA Published on 2025-02-04

FDA

Know Which Medication Is Right for Your Seasonal Allergies
Source: FDA Published on 2024-06-25
Sani-Care Salon Products, Inc. - 673747 - 04/24/2024
Source: FDA Published on 2024-06-25
Glenmark Pharmaceuticals Inc., USA Issues Voluntary Nationwide Recall for Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due to Failed Dissolution
Source: FDA Published on 2024-06-25
Report | Drug Shortages: Root Causes and Potential Solutions
Source: FDA Published on 2024-06-24
FDA approves treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults
Source: FDA Published on 2024-06-24
Facilitating Generic Drug Product Development through Product-Specific Guidances - 04/25/2024
Source: FDA Published on 2024-06-24
Modernizing the New Drugs Regulatory Program
Source: FDA Published on 2024-06-24
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Source: FDA Published on 2024-06-21
Public Workshop: Best Practices for Meeting Management Under PDUFA VII - 07/22/2024
Source: FDA Published on 2024-06-21
Center for Drug Evaluation and Research National Survey on Numerical Claims in Prescription Drug Advertising
Source: FDA Published on 2024-06-20
Infla-650 contains hidden drug ingredients
Source: FDA Published on 2024-06-20
Cefdinir - Oral products
Source: FDA Published on 2024-06-20
Considerations in Demonstrating Interchangeability With a Reference Product: Update
Source: FDA Published on 2024-06-20
Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection
Source: FDA Published on 2024-06-20
FDA updates guidance on interchangeability
Source: FDA Published on 2024-06-20

Biosimilar-main-slider

Upcoming Events

News &
Events

Explore

Drag